FIELD: chemistry.
SUBSTANCE: invention relates to novel bioisosteres of actinonin of general formula (I) 
, as well as to pharmaceutically acceptable salts thereof and pharmaceutical compositions based on said compounds, with peptide deformylase (PDF) inhibitory activity, as well as to use of the compounds or pharmaceutical compositions based on said compounds to prepare medicinal agents. In general formula (I) R1 is a hydrogen atom, R2 is a hydrogen atom, (C1-C6)alkyl residue, hetero(C1-C6)alkylphenyl residue, where the heteroatom is sulphur, R3 is a hydrogen atom, R4 is (C1-C6)alkyl residue, (C3-C7)cycloalkyl residue, R6 is a hydrogen atom, n is 1, 2 or 3. Values of substitute R5 are given in the formula of invention.
EFFECT: new compounds have useful biological activity.
8 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTION | 2004 |
|
RU2397982C2 |
| INTERMEDIATE PRODUCTS FOR PRODUCING OXAZOLIDINONE AND QUINOLONE DERIVATIVES | 2004 |
|
RU2373203C2 |
| IMIDAZO[1,2-a]PYRIDINE DERIVATIVES USED AS PEPTIDE DEFORMYLASE INHIBITORS | 2006 |
|
RU2409575C2 |
| IMIDAZO[1,2,-a]PYRIDINE DERIVATIVES TO BE USED AS PEPTIDE DEFORMYLASE (PDF) INHIBITORS | 2006 |
|
RU2420526C2 |
| COVERED MOLECULAR SIEVE | 2007 |
|
RU2458735C2 |
| 8-OXY-QUINOLINE DERIVATIVES AS BRADYKININ B2 RECEPTOR MODULATORS | 2008 |
|
RU2512541C2 |
| HYBRID ANTIBACTERIAL AGENTS OXAZOLIDINONE-QUINOLONE INTENDED FOR PARENTERAL ADMINISTRATION FOR TREATMENT OR PREVENTION OF BACTERIAL DISEASES | 2014 |
|
RU2702364C2 |
| METABOLICALLY STABLE CYP-EICOSANOID ANALOGUES FOR THE TREATMENT OF CARDIOLOGICAL DISEASES | 2016 |
|
RU2761438C2 |
| NOVEL MONOMERS AND OLIGOMERS OF PEPTIDE NUCLEIC ACIDS | 2015 |
|
RU2693827C2 |
| NOVEL INDOLE DERIVATIVES HAVING IκB KINASE β INHIBITING ACTIVITY | 2008 |
|
RU2470918C2 |
